Related Experiment Video
Updated: Jan 14, 2026

Generation and Characterization of Right Ventricular Myocardial Infarction Induced by Permanent Ligation of the Right Coronary Artery in Mice
Published on: February 1, 2022
An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial
Eric J Velazquez1, Gary S Francis, Paul W Armstrong
1Division of Cardiology, Department of Medicine, Duke University Medical Center and Duke Clinical Research Institute, P.O. Box 17969, Durham, NC 27715, USA. velaz002@dcri.duke.edu
Insights
Heart failure (HF) and/or left ventricular systolic dysfunction (LVSD) are common after myocardial infarction (MI). These conditions significantly increase in-hospital mortality risk and complications for MI patients.
Area of Science:
- Cardiology
- Internal Medicine
- Clinical Research
Background:
- Heart failure (HF) and/or left ventricular systolic dysfunction (LVSD) significantly increase short- and long-term risks following myocardial infarction (MI).
- The incidence, predictors, and outcomes of HF/LVSD in a large, international MI population require detailed description.
Purpose of the Study:
- To analyze the contemporary incidence, outcomes, and predictors of HF and/or LVSD before discharge in acute myocardial infarction (MI) patients.
- To assess the impact of HF/LVSD on in-hospital mortality and other cardiovascular events post-MI.
Main Methods:
- Analysis of the VALIANT registry, including 5573 consecutive MI patients from 84 hospitals in nine countries (1999-2001).
- Construction of a multivariable logistic survival model to determine adjusted mortality risk for patients with in-hospital HF/LVSD.
- Testing baseline variables for associations with in-hospital HF/LVSD.
Main Results:
- 42% of 5566 analyzed MI patients experienced HF and/or LVSD during hospitalization.
- In-hospital mortality was 13.0% for patients with HF/LVSD versus 2.3% for those without.
- In-hospital HF/LVSD was associated with a 4.12-fold increased hazard ratio for mortality and higher rates of other cardiovascular events.
Conclusions:
- HF and/or LVSD are prevalent in contemporary MI patients, preceding 80.3% of in-hospital deaths.
- Survivors of early MI-associated HF/LVSD face increased complications, longer hospital stays, and higher in-hospital mortality.
- While baseline variables identify high-risk patients, they are less likely to receive indicated procedures and therapies.
Aims:
We analysed the contemporary incidence, outcomes, and predictors of heart failure (HF) and/or left ventricular systolic dysfunction (LVSD) before discharge in patients with acute myocardial infarction (MI). The baseline presence of HF or LVSD, or its development during hospitalisation, increases short- and long-term risk after MI, yet its incidence, predictors, and outcomes have not been well described in a large, international, general MI population.
Methods And Results:
The VALIANT registry included 5573 consecutive MI patients at 84 hospitals in nine countries from 1999 to 2001. A multivariable logistic survival model was constructed using baseline variables to determine the adjusted mortality risk for those with in-hospital HF and/or LVSD. Baseline variables were also tested for associations with in-hospital HF and/or LVSD. Of the 5566 patients analysed, 42% had HF and/or LVSD during hospitalisation. Their in-hospital mortality rate was 13.0% compared with 2.3% for those without HF and/or without LVSD. After adjustment for other baseline risk factors, in-hospital HF and/or LVSD carried a hazard ratio for in-hospital mortality of 4.12 (95% confidence interval: 3.08-5.56). Patients with HF and/or LVSD also had disproportionately higher rates of other cardiovascular events.
Conclusions:
HF and/or LVSD is common in the general contemporary MI population and precedes 80.3% of all in-hospital deaths after MI. Survivors of early MI-associated HF and/or LVSD have more complications, longer hospitalisations, and are more likely to die during hospitalisation. Although baseline variables can identify MI patients at highest risk for HF and/or LVSD, such patients are less likely to receive indicated procedures and medical therapies.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
09:20Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure V: Medical Management
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure III: Clinical Manifestations
Heart Failure II: Pathophysiology
Heart Failure I: Introduction